An experimental Roche Holding AG drug, designed to unleash the body’s immune system to fight cancer, shrank tumors in patients with advanced bladder cancer in a new clinical trial, the drug maker said Monday.
from WSJ.com: US Business http://ift.tt/1O86LaE
via IFTTT
No comments:
Post a Comment